Division of Cardiology

Medicine & Life Sciences

1. Heart Failure 100%
2. Myocardial Infarction 87%
3. Percutaneous Coronary Intervention 70%
4. Coronary Artery Disease 70%
5. Atrial Fibrillation 70%
6. Acute Coronary Syndrome 56%
7. Stents 55%
8. pitavastatin 50%
9. Computed Tomography Angiography 46%
10. Japan 42%
11. Hydroxymethylglutaryl-CoA Reductase Inhibitors 41%
12. Optical Coherence Tomography 41%
13. Heart-Assist Devices 39%
14. Brain Natriuretic Peptide 38%
15. Coronary Angiography 37%
16. Coronary Vessels 34%
17. Myocarditis 31%
18. Echocardiography 29%
19. Registries 28%
20. Lipids 26%
21. Atherosclerotic Plaques 26%
22. Myocardial Perfusion Imaging 25%
23. Hemorrhage 24%
24. Therapeutics 23%
25. Stroke Volume 23%
26. Heart Transplantation 22%
27. Heart 21%
28. Chronic Renal Insufficiency 21%
29. Mortality 21%
30. Confidence Intervals 20%
31. Non-ST Elevated Myocardial Infarction 20%
32. Everolimus 20%
33. ST Elevation Myocardial Infarction 20%
34. Thrombosis 19%
35. Atorvastatin 19%
36. Glomerular Filtration Rate 18%
37. Pathologic Constriction 18%
38. Eicosapentaenoic Acid 18%
39. Rivaroxaban 18%
40. Tomography 18%
41. Coronavirus 18%
42. Extracorporeal Membrane Oxygenation 17%
43. Incidence 17%
44. Cardiology 17%
45. Anticoagulants 17%
46. Perfusion 16%
47. Exercise 16%
48. LDL Cholesterol 16%
49. Left Ventricular Dysfunction 16%
50. Sirolimus 16%
51. Unstable Angina 15%
52. Transplants 15%
53. Safety 15%
54. Serum 14%
55. Hospital Mortality 14%
56. Equipment and Supplies 14%
57. Warfarin 14%
58. Cardiac Rehabilitation 14%
59. Sarcoidosis 13%
60. Acute Kidney Injury 13%
61. Biomarkers 13%
62. Stroke 13%
63. Subarachnoid Hemorrhage 13%
64. Multicenter Studies 13%
65. Coronary Stenosis 12%
66. Troponin 12%
67. Drug-Eluting Stents 12%
68. Angiography 12%
69. Single-Photon Emission-Computed Tomography 12%
70. Elderly 12%
71. Blood Vessels 12%
72. Frailty 11%
73. Atherosclerosis 11%
74. Pressure 11%
75. iodofiltic acid 11%
76. ROC Curve 11%
77. Dilated Cardiomyopathy 11%
78. Cause of Death 11%
79. Stable Angina 11%
80. Regression Analysis 11%
81. Angiotensin Receptor Antagonists 11%
82. Cardiogenic Shock 11%
83. Troponin I 11%
84. Catheter Ablation 10%
85. Heart Diseases 10%
86. Cohort Studies 10%
87. Secondary Prevention 10%
88. Population 10%
89. Pandemics 10%
90. Electrocardiography 10%
91. Hypertrophic Cardiomyopathy 10%
92. Cardiac Resynchronization Therapy 10%
93. Prospective Studies 9%
94. pentadecanoic acid 9%
95. Hospitalization 9%
96. Fatty Acid-Binding Proteins 9%
97. Tachycardia 9%
98. Peripheral Arterial Disease 9%
99. Transcatheter Aortic Valve Replacement 9%
100. Left Ventricular Function 9%